港股異動 | 績後獲機構唱好 歐舒丹(0973.HK)漲超10%逼近歷史高位
格隆匯12月3日丨歐舒丹(0973.HK)大幅拉昇漲超10%,報32.45港元逼近歷史高價,總市值達473億港元。日前公佈中期業績,銷售淨額約6.96億歐元,同比增長12.9%;溢利5988.8萬歐元,同比增長297.6%。花旗預計經營利潤率在短至中期可繼續改善,主因其銷售組合在區域、品牌及渠道上均有改善。維持“買入”評級,目標價升至37.6港元;麥格理將歐舒丹2022和2023財政年度盈利預測分別上調13%和8.8%,重申跑贏大市評級,目標價上調至38港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.